MiR-24 Tumor Suppressor Activity Is Regulated Independent of p53 and through a Target Site Polymorphism

Prasun J. Mishra; Bo Song; Pravin J. Mishra; Yuan Wang; Rita Humeniuk; Debabrata Banerjee; Glenn Merlino; Jingfang Ju; Joseph R. Bertino

doi:10.1371/journal.pone.0008445

Loading metrics

Open Access

Peer-reviewed

Research Article

MiR-24 Tumor Suppressor Activity Is Regulated Independent of p53 and through a Target Site Polymorphism

Prasun J. Mishra,

Affiliations Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America, Department of Pharmacology and Medicine, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, New Jersey, United States of America
⨯
Bo Song,

Affiliation Translational Research Laboratory, Department of Pathology, Stony Brook University Medical Center, Stony Brook, New York, United States of America
⨯
Pravin J. Mishra,

Affiliation Department of Pharmacology and Medicine, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, New Jersey, United States of America
⨯
Yuan Wang,

Affiliation Translational Research Laboratory, Department of Pathology, Stony Brook University Medical Center, Stony Brook, New York, United States of America
⨯
Rita Humeniuk,

Affiliation Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America
⨯
Debabrata Banerjee,

Affiliation Department of Pharmacology and Medicine, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, New Jersey, United States of America
⨯
Glenn Merlino,

Affiliation Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America
⨯
Jingfang Ju,

Affiliation Translational Research Laboratory, Department of Pathology, Stony Brook University Medical Center, Stony Brook, New York, United States of America
⨯
Joseph R. Bertino

* E-mail: bertinoj@umdnj.edu

Affiliation Department of Pharmacology and Medicine, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, New Jersey, United States of America
⨯

MiR-24 Tumor Suppressor Activity Is Regulated Independent of p53 and through a Target Site Polymorphism

Prasun J. Mishra,
Bo Song,
Pravin J. Mishra,
Yuan Wang,
Rita Humeniuk,
Debabrata Banerjee,
Glenn Merlino,
Jingfang Ju,
Joseph R. Bertino

Published: December 24, 2009
https://doi.org/10.1371/journal.pone.0008445

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Colorectal cancer
Is the Subject Area "Colorectal cancer" applicable to this article?

Thanks for your feedback.
MicroRNAs
Is the Subject Area "MicroRNAs" applicable to this article?

Thanks for your feedback.
Transfection
Is the Subject Area "Transfection" applicable to this article?

Thanks for your feedback.
Small interfering RNA
Is the Subject Area "Small interfering RNA" applicable to this article?

Thanks for your feedback.
Cell proliferation
Is the Subject Area "Cell proliferation" applicable to this article?

Thanks for your feedback.
Renal cancer
Is the Subject Area "Renal cancer" applicable to this article?

Thanks for your feedback.
Cell cycle and cell division
Is the Subject Area "Cell cycle and cell division" applicable to this article?

Thanks for your feedback.
Cell immortalization
Is the Subject Area "Cell immortalization" applicable to this article?

Thanks for your feedback.